The press release that ignited the action:
Ponte Nossa Acquires Visijet
IRVINE, Calif.--(BW HealthWire)--Ponte Nossa Acquisition Corp. (OTCBB:PNSA) announced today that they have successfully negotiated the acquisition of Visijet, Inc., a privately-held ophthalmic medical device company located in Irvine.
Visijet, founded in 1996, is the developer of an exciting new technology that uses a high pressure micro beam of water to perform surgical cuts for ocular procedures -- similarly to how a laser uses light to dissect tissue. The company's first product, approved by the FDA in October, 2000 is the Hydrokeratome(R), an innovative, patented device that offers "bladeless" surgery to perform the cutting of the cornea that is required in LASIK surgery. LASIK surgery is a procedure growing in popularity that allows individuals to have corrected visual acuity without glasses or contact lenses. It is estimated that more than 3 million LASIK surgeries were performed last year worldwide.
Visijet's second product, the Pulsatome(R), is a device that uses the waterjet technology to remove cataracts -- the most performed surgical procedure in the world. The Pulsatome(R) will provide entry into an estimated $8 billion cataract market worldwide. FDA approval for the device is anticipated in early 2002. In addition, Visijet has several ophthalmic devices utilizing the waterjet technology under development.
"We are very excited about Visijet," said Thomas F. DiMele, president of Ponte Nossa. "The advantages the technology offers over products currently available are significant and the company's intellectual properties, management, R&D, and distribution channels are well established. We look forward to significant growth."
Specifics of the transaction to be announced in a timely manner.
Forward-Looking Statement
Except for historical information contained herein, the matters discussed in this news release are forward-looking statements within the meaning of the Securities Exchange Act that involve risks and uncertainties that could cause actual results to differ materially from those expressed. These matters include, but are not limited to, information about the Company's technologies and products, financial situations, or business opportunities. This news release shall not constitute an offer to sell or the solicitation of an offer to sell any of these securities.
CONTACT:
Mitchell & Company (for Ponte Nossa)
Diane Mitchell, 949/474-7020
KEYWORD: CALIFORNIA
BW2150 JUL 23,2001
5:07 PACIFIC
8:07 EASTERN |
